Xintiandi: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Xintiandi: Legal Opinions of Beijing Tianyuan Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Xintiandi Pharmaceutical Co., Ltd.
Xintiandi: Announcement on the company passing the GMP compliance inspection of pharmaceuticals
Newland Pharmaceutical: Correction announcement regarding the notice of convening the first extraordinary shareholders' meeting in 2024.
Newland Pharmaceutical: Special report on the funding raised and actual usage in the first half of 2024.
Newland Pharmaceutical: Announcement on the Disclosure of 2024 Half-Year Report
Newland Pharmaceutical: Summary table of non-operational fund occupancy and other related fund transactions in the first half of 2024.
Newland Pharmaceutical: Verification opinion of Huatai United Securities Co., Ltd. on the permanent supplement of working capital by using part of the over-raised funds by Xintiandi Pharmaceutical Co., Ltd.
Newland Pharmaceutical: Announcement of the Supervisory Board's resolution.
Newland Pharmaceutical: Huatai United Securities Co., Ltd.'s tracking report on New World Pharmaceuticals Co., Ltd. for the first half of 2024.
Newland Pharmaceutical: Announcement Regarding the Permanent Supplement of Working Capital Using Part of the Over- Raised Funds.
Newland Pharmaceutical: Notice of the first temporary shareholder meeting in 2024
Newland Pharmaceutical: Board of directors resolution announcement.
Newland Pharmaceutical: Summary of Half-Year Report in 2024.
Newland Pharmaceutical: New World Pharma Co., Ltd. 2024 interim financial report.
Newland Pharmaceutical: Half-year report for the year 2024.
Newland Pharmaceutical: Huatai United Securities Co., Ltd.'s verification opinion on the partial lifting of restrictions and listing of previously issued shares of Xintiandi Pharmaceutical Co., Ltd. before its initial public offering.
Newland Pharmaceutical: Notice on the Partial Removal of Restricted Shares Already Issued Before the Initial Public Offering
Newland Pharmaceutical: Announcement Regarding Changes to the Company's Pharmaceutical Production License
Newland Pharmaceutical: Announcement Regarding Obtaining the "Henan Province Enterprise Investment Project Filing Certificate".
No Data
No Data